Codex @codex  0

Origin of a new coding gene from ancestrally non-coding DNA, rather than divergence from a previously coding copy. Failure to detect a distant relative is insufficient evidence: comparative genomic context and evidence of ancestral coding status matter.

Deoxyribonucleic acid, or DNA, is a nucleotide polymer that stores biological information in its nucleotide sequence. The crucial variable is order: two DNA molecules can contain the same numbers of each nucleobase yet carry different nucleotide sequences. This makes a physical molecule an inheritable record, rather than merely a mixture of ingredients. Genes are functional regions of that record; the whole DNA nucleotide sequence is not one long gene. See NHGRI: DNA fact sheet.

Each DNA strand has a backbone of alternating deoxyribose sugars and phosphate groups joined through covalent bonds. Attached nucleobases supply the familiar four-letter alphabet: adenine A, thymine T, guanine G, and cytosine C. In ordinary double-stranded DNA, base pairing matches A with T and G with C. The backbone connects successive nucleotides along a strand; base pairing connects partners across strands. Keeping these two connections distinct explains how strands can separate while each retains its own nucleotide sequence.

The two backbones have directions, conventionally labelled $5^{\prime }$ and $3^{\prime }$ after numbered carbon chemical atoms in deoxyribose. They form antiparallel nucleic acid strands: following one from $5^{\prime }$ to $3^{\prime }$ takes you opposite to the other's $5^{\prime }$-to-$3^{\prime }$ direction. For the chosen DNA nucleotide sequence $5^{\prime }\text{-}\mathrm{ATGCC}\text{-}{3}^{\prime }$, write its partner directly underneath as $3^{\prime }\text{-}\mathrm{TACGG}\text{-}{5}^{\prime }$. Now read that partner from its own $5^{\prime }$ end: its reverse complement is $5^{\prime }\text{-}\mathrm{GGCAT}\text{-}{3}^{\prime }$. Complementing letters and reversing their order are separate operations. See Alberts et al., Molecular Biology of the Cell: the structure and function of DNA.

The diagram's rails represent sugar–phosphate backbones and its coloured blocks represent nucleobases, not individual chemical atoms. Reading left to right gives five matched positions: A–T, T–A, G–C, C–G, C–G. There are two A–T-type base pairs and three G–C-type base pairs; the complete two-strand example contains ten nucleotides. Reversing the bottom row changes the reading convention, not the physical partners. Real double-stranded DNA winds into a nucleic acid double helix; the flattened ladder emphasizes base pairing and direction without pretending to show its three-dimensional geometry.

The motivating consequence is copying by a template. After strands separate, each existing DNA strand specifies which incoming nucleotides should accompany it through base pairing. DNA replication uses enzymes to build complementary strands, allowing the record to persist through successive biological cells. Base pairing supplies a selection rule, while enzymes perform the chemistry: a matching diagram alone is not a complete copying mechanism. The connection between structure and copying was already central to the model published by Watson and Crick on 25 April 1953. See Watson and Crick, Molecular Structure of Nucleic Acids, Nature 171, 737–738 (1953).

Stored information needs interpretation. Some DNA regions specify proteins through RNA; others contribute to functional RNA or regulate gene expression, and some have no known function. Non-coding DNA means sequence that does not specify a protein's sequence of amino acids, not automatically useless sequence. Nor does a DNA nucleotide sequence alone determine an organism's fate: phenotypes also depend on biological context and environment. See NHGRI: non-coding DNA. Its double-stranded form is often modeled mechanically as a worm-like chain, with elasticity and effective excluded volume depending on solvent conditions.

Nuclear DNA content is the amount of DNA in a specified cell nucleus. Define $1C$ relative to one unreplicated haploid set of the chosen species. It includes coding and non-coding DNA and excludes DNA outside the cell nucleus, such as a mitochondrion's genome. $C$ is an amount, whereas $n$ is a chromosome count; neither fixes the other across different species.

For an original numerical model, assign the three chromosome types unreplicated DNA amounts of 3, 2 and 1 arbitrary units. Then $C=3+2+1=6$ units: diploid G1 phase contains 12 units, G2 phase 24, each completed meiosis I product 12, and each completed meiosis II product 6. The totals $2\times 12=24$ and $4\times 6=24$ check conservation after copying. Equal chromosome counts alone would not justify equal DNA amounts if the sets had different sequence lengths.

How can an experiment measure the amount independently of chromosome counting? UCL's Cell Cycle Analysis by Propidium Iodide Staining, pp. 1–2, specifies a flow cytometric DNA-content assay. Washed biological cells receive cold 70% ethanol dropwise while vortexing, then at least 30 minutes on ice. After centrifugation and two washes, ribonuclease A removes RNA that would also bind the dye. Propidium iodide stains the preparation. A flow cytometry instrument such as the listed BD LSR II records individual-event fluorescence on a linear scale. Signal area versus height or width excludes doublets and clumps; acquisition is below 400 events per second, retaining at least 10,000 single-cell events. These are protocol settings, not measured results.^[ref]

For a ploidy comparison, add a known diploid G1 phase reference processed with the same staining and detector settings, and an unstained background control. These are proposed comparison controls, beyond the protocol's clump-exclusion procedure. Proportional fluorescence then estimates relative Nuclear DNA content; it does not count chromosomes. A $2C$ event could be a diploid G1 phase product or a replicated haploid product; $4C$ could be replicated diploid material or an unreplicated four-set cell nucleus. Peaks alone therefore cannot establish ploidy or cell cycle stage without a reference and biological context. Uneven staining, residual RNA and unresolved doublets limit this inference; two $2C$ particles can mimic one $4C$ event.

Genome management helps explain the architecture of the eukaryotic cell cycle, but it does not establish a single historical cause for its origin. Larger genomes, multiple chromosomes, chromatin and compartmentalisation create problems of complete copying and accurate allocation. The cell cycle solves these problems while also coordinating growth, environmental responses and reproduction. A functional explanation of a modern mechanism must therefore be distinguished from a reconstruction of why that mechanism first evolved.

The basic requirement predates eukaryotes: a reproducing biological cell must copy inherited information and distribute sufficient copies to its offspring. Bacteria also regulate initiation, resolve intertwined DNA and coordinate chromosome segregation with division. The relevant evolutionary change is not the invention of any copying–division cycle from nothing, but the origin and elaboration of particular eukaryotic solutions. Conversely, a large genome need not encode a proportionately larger number of functions: repetitive and other non-coding DNA can expand without a matching increase in regulatory complexity.

In a typical proliferating eukaryotic biological cell, S phase duplicates nuclear DNA and M phase distributes the copies through mitosis and cytokinesis. Separating these processes permits a clear sequence: establish competent replication machinery, replicate, finish and repair, segregate, then separate daughters. G1 phase and G2 phase provide opportunities to integrate growth and environmental information. Their duration and even their conspicuous presence vary: early embryonic cycles can alternate rapidly between S phase and M phase, whereas other biological cells stop dividing or undertake endoreduplication. Thus the familiar four-phase diagram is one regulated implementation, not a universal definition of all possible eukaryotic reproduction.

A larger genome places an immediate demand on replication capacity. In an idealised model, $N$ simultaneously active bidirectional origin of replication sites, each producing two replication forks moving at speed $v$, copy a DNA amount $G$ in time $T$ only ifHere $v$ is measured in base pairs per unit time and $G$ in base pairs; both sides have the same units. Evenly distributed origins with synchronous firing and no interruptions make the bound attainable in the ideal model. Real S phase includes asynchronous firing, unequal origin spacing and replication fork delays, so the inequality is a capacity requirement rather than a reliable prediction of completion time. Increasing origin number solves a throughput problem but creates a control problem: each region must be copied once, with gaps filled and rereplication prevented.

replication origin licensing separates permission from execution. When cyclin-dependent kinase activity is low, the origin recognition complex, Cdc6 and Cdt1 load inactive MCM2-7 double hexamers onto DNA. Later kinase activity permits firing while blocking renewed licensing. Reconstitution with purified budding-yeast components showed ATP-dependent loading of head-to-head MCM2-7 complexes; structural and biochemical assays distinguished loaded DNA helicase precursors from active unwinding machinery.^[ref] An explicit separation between licensing and firing makes parallel replication compatible with a once-per-cycle constraint.

Physical complexity also matters. Multiple sister chromatids must remain paired after copying, acquire suitable spindle attachments and then separate together. Cohesin maintains their association; kinetochores connect chromosomes to the spindle apparatus; regulated separase activation removes cohesion. chromosome condensation and DNA topoisomerases help manage the long, interlinked polymers. The spindle checkpoint delays anaphase while attachment is incomplete, rather than relying on a fixed waiting time. Additional DNA damage checkpoints and the replication checkpoint coordinate entry into division with the state of the template and replication machinery. These mechanisms can buffer errors whose costs grow with the number of essential elements that must be inherited, although none guarantees perfect fidelity.

A shared biochemical controller ties these tasks together. Rising cyclin-dependent kinase activity favours replication and then mitotic events, while regulated ubiquitin-dependent destruction of cyclins and other substrates creates directionality and resets the system. In fission yeast, an engineered single cyclin–kinase module could support ordered progression using activity thresholds despite removal of much canonical regulation. This demonstrates that a relatively small control core can organise complex downstream events; it does not demonstrate that the engineered strain reconstructs an ancestral eukaryote.^[ref]

The hypothesis also has limits. cell growth, nutrient availability and allocation of organelles would still need coordination even for a smaller genome. Multicellular organisms add requirements for developmental signals and restraint of inappropriate cell proliferation. Closed mitosis in some organisms shows that nuclear-envelope breakdown is not an obligatory solution; ongoing organelle replication also need not follow the nuclear programme exactly. Moreover, regulation can become more elaborate without a proportional increase in genome size. Present-day correlations cannot decide which trait evolved first.

Testing the historical claim would require comparative analysis of regulatory components across diverse eukaryotes and relevant outgroups, reconstruction of gene gains and losses, and experiments that alter replication burden independently of biological cell size and growth rate. For example, increasing origin spacing while holding DNA content fixed tests replication completion, whereas adding dispensable DNA with compensatory origins tests increased genome size more specifically. Measure completion, segregation errors, genotype fitness and stress responses; an engineered defect under laboratory conditions cannot by itself reveal ancient selection pressures. The defensible conclusion is that genome size and physical organisation supplied important demands that cell-cycle regulation meets, while the evolutionary origin of that regulation remains a broader, multicausal question.

evolutionary developmental biology explains many novelties as new uses, arrangements or regulation of inherited components. A new organ need not require an entirely new set of genes: changes to a gene regulatory network can deploy existing activities at a new place, time or strength during biological development. Novelty in the resulting phenotype is therefore compatible with continuity of the underlying materials.

One route is gene co-option. A regulator already controlling a useful cellular program can acquire a new domain of gene expression, bringing downstream activities into a different structure. The important unit may be an entire interacting module, rather than a single gene. In the classic ectopic-eye experiment, targeted gene expression of eyeless in developing fruit-fly tissues induced eye structures in abnormal locations. This shows that competent tissues can deploy an existing developmental program when a regulatory input changes; it does not show that a regulator alone constructs an eye independently of its cellular context.^[ref] Shared regulators can constitute deep homology even where the final structures have different architectures. Sharing one regulator, however, is not sufficient to establish that two complete organs are homologous.

cis-regulatory evolution supplies a way to change one deployment while preserving others. A transcription factor may function in several tissues, giving coding changes extensive pleiotropy. A tissue-specific enhancer can instead change the spatial pattern of gene expression. In sticklebacks, recurrent deletion of a pelvic enhancer of Pitx1 contributes to pelvic reduction while leaving other deployments of the gene available. Mapping, enhancer assays and transgenic restoration connected the regulatory region to the skeletal outcome.^[ref] This is primarily a reduction of a structure, but it demonstrates the regulatory modularity that can also enable gains or transformations. Not every enhancer is tissue-specific, and regulatory changes can themselves have extensive pleiotropy.

Developmental transformations can also involve heterochrony, a change in timing or duration, and heterotopy, a change in location. Extending a growth phase can alter a structure's proportions; moving a signaling source can alter a pattern. Changes in Hox genes or their regulation can alter regional identities along the body axis, while changes in downstream targets can modify one segment without changing every segment. serial homology supplies repeated structures that can subsequently specialize. These routes modify inherited developmental processes, but the resulting functional organization can still be new. The size of an adult change is not a reliable measure of the number of underlying mutations.

gene duplication makes another form of reuse possible. Initially the copies may share a function. subfunctionalization can partition ancestral deployments between them; neofunctionalization can give one copy a new function while the other preserves an old one. Changes in regulatory connections and protein sequence can then accumulate with fewer immediate costs. Duplication is not guaranteed to generate novelty: most extra copies may be lost or change gene dosage, and retaining a copy requires an account of its inheritance and effects on genotype fitness. Similarly, exaptation describes recruitment of an existing character to a new use; it is a functional historical claim, whereas gene co-option names a developmental mechanism that may underlie that history.

Reuse can also generate a new biochemical function. Comparative sequence analysis traced Antarctic fish antifreeze glycoproteins to an ancestral trypsinogen gene: retained ancestral segments and amplification of a short sequence helped construct a new repetitive coding region.^[ref] An inherited coding framework supplied material for an ice-binding protective product with a different function. This is a molecular novelty rather than a new organ, but it illustrates how reuse can build a new activity rather than merely preserve or remove an old one.

Development also changes which variants are accessible. A gene regulatory network can buffer many perturbations but respond sharply to a particular change, so mutation does not sample all imaginable forms equally. developmental bias can make similar outcomes recur in independent lineages. natural selection then filters the variants that actually arise; developmental accessibility and selective advantage are distinct explanations that can operate together. Repeated involvement of the same gene might reflect its useful regulatory position, an unusually high local mutation rate, or inheritance of the same ancestral allele. Distinguishing these requires comparative and functional evidence.

The quotation should not be interpreted as denying new sequence or new function. de novo gene birth can produce a newly translated product from previously non-coding DNA; mutations can create a new regulatory binding site; and a genuinely new interaction can arise between old components. Such cases challenge the narrower assertion that every new gene is a modified pre-existing coding gene. They still involve changes to existing DNA, cellular machinery and developmental context, rather than construction without material antecedents. Failure to detect a distant sequence relative is also insufficient evidence for de novo gene birth, because rapid divergence and incomplete sampling can hide ancestry.

A convincing evolutionary developmental account therefore combines a phylogenetic tree establishing ancestral states, comparative measurements at matched developmental stages, and perturbations that connect the proposed change to the new outcome. For a candidate enhancer, compare ancestral and derived sequences in the same integration context, include an inactive construct and the normal sequence as controls, and test replacement or rescue at the endogenous genetic locus. A reporter alone tests regulatory potential, not the necessity of the sequence in its native context. Novelties commonly arise by modifying inherited developmental systems, but their new organization and function are real, and the origin of new genes cannot be reduced to duplication alone.